European Life Science Instrumentation Market 2026-2035

Description

List of Tables

European Life Science Instrumentation Market Size, Share & Trends Analysis Report by Technology (Chromatography, Spectroscopy, Polymerase Chain Reaction (PCR), Clinical Chemistry Analyzers, Immunoassays, Next Generation Sequencing (NGS), Flow Cytometry, Microscopy, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Research Institutes, and Hospitals & Laboratories), Forecast Period (2026-2035)

Industry Overview

European life science instrumentation market was valued at $16.9 billion in 2025 and is projected to reach $30.7 billion by 2035, growing at a CAGR of 6.2% during the forecast period (2026-2035). The European life science instrumentation market is witnessing consistent growth due to advances in laboratory automation and analytical precision. Research institutions and diagnostic centers are increasingly adopting high-performance instruments to enhance data accuracy. Analytik Jena GmbH and Malvern Panalytical Ltd. are expanding their product offerings across Europe, addressing rising demand in molecular biology and clinical applications. The growing focus on precision medicine and biomolecular studies is further driving instrument adoption. Public-private collaborations are encouraging the development of specialized analytical systems tailored to European regulatory needs.

Market Dynamics

Rising Integration of Spectroscopy in Advanced Research Applications

The European life science instrumentation market is witnessing notable growth driven by the expanding use of spectroscopy in biological and chemical research. Companies such as Agilent Technologies are enhancing analytical precision through advanced spectroscopic instruments used in molecular analysis and drug discovery. This shift towards precise molecular characterization is enabling faster and more reliable results in laboratory settings. Increasing adoption across academic and clinical laboratories is also reinforcing market expansion. Moreover, ongoing technological innovations are supporting more compact and efficient instruments, aligning with the region's focus on data accuracy and automation.

Growing Demand from Pharmaceutical and Biotechnology Sectors

The pharmaceutical and biotechnology industries across Europe are significantly contributing to the market's advancement. Firms like Thermo Fisher Scientific are supplying high-performance analytical systems that streamline drug development and quality assurance processes. The rising emphasis on biopharmaceutical production and personalized medicine has created consistent demand for advanced life science tools. Research laboratories are increasingly investing in automation and high-throughput systems to enhance productivity. Additionally, regulatory compliance and the growing number of clinical trials in Europe continue to fuel equipment upgrades and new installations across the sector.

Market Segmentation

Based on technology, the market is segmented into chromatography, spectroscopy, polymerase chain reaction (PCR), clinical chemistry analyzers, immunoassays, next-generation sequencing (NGS), flow cytometry, microscopy, and others.
Based on the end-user, the market is segmented into pharmaceutical & biotechnology companies, research institutes, and hospitals & laboratories.

Spectroscopy Segment to Lead the Market with the Largest Share

Spectroscopy technologies are playing a crucial role in advancing Europe's Life Science Instrumentation Market. The method's ability to deliver precise molecular and chemical analysis makes it indispensable for pharmaceutical formulation and quality assurance. Shimadzu Europa GmbH and PerkinElmer Inc. (Europe) have introduced advanced spectroscopic platforms designed for life science laboratories and environmental testing facilities. Increasing application in protein structure identification and metabolomics research is strengthening market performance. Academic laboratories and contract research organizations are also expanding their analytical capabilities using these systems. As a result, spectroscopy continues to form the backbone of Europe's analytical instrumentation landscape.

Pharmaceutical And Biotechnology Companies: A Key Segment in Market Growth

The expansion of the pharmaceutical and biotechnology industries across Europe is significantly boosting the life science instrumentation market. Continuous drug discovery programs and the rising production of biologics are increasing demand for high-end analytical and diagnostic systems. bioMerieux SA and Siemens Healthineers AG are among the leading companies providing advanced immunoassay and molecular diagnostic instruments for biopharmaceutical applications. Growing collaborations between research institutions and biotech startups are also driving the use of next-generation sequencing and chromatography systems. Additionally, the focus on regulatory compliance and process standardization is encouraging technology upgrades. This growing integration of instrumentation into biopharma workflows underpins Europe's evolving research ecosystem.

Regional Outlook

European life science instrumentation market is further divided by countries, including the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe.

Germany Dominates the Market with a Major Share

Germany's life science instrumentation market is expanding rapidly, supported by strong industrial research and academic collaboration. The country's well-established pharmaceutical and diagnostic sectors are investing heavily in modern analytical instruments. Siemens Healthineers AG and Analytik Jena GmbH continue to lead innovation with new clinical chemistry analyzers and spectroscopy solutions for laboratories and hospitals. Increasing demand for advanced molecular testing tools is fostering partnerships with biotechnology firms and universities. Government initiatives promoting R&D and precision healthcare are further strengthening the market outlook. This momentum reflects Germany's growing influence as a center for life science innovation in Europe.

Market Players Outlook

The major companies operating in the European life science instrumentation market include Analytik Jena GmbH + Co. KG, bioMerieux SA, Malvern Panalytical Ltd., Siemens Healthineers AG, Thermo Fisher Scientific GmbH, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.

Recent Developments

In April 2025, QIAGEN announced the upcoming launch of three automated sample preparation instruments scheduled for 2025-2026. The releases aim to increase laboratory throughput and automation for molecular diagnostics and genomic analysis. QIAGEN's initiative strengthens its footprint in automated molecular laboratory solutions.
In December 2024, Roche launched its cobas Mass Spec solution after securing EU CE mark approval. This includes the cobas i 601 analyzer and Ionify reagent packs for high-precision steroid hormone assays. The new mass spectrometry platform marks Roche's major step into the combined clinical chemistry and proteomics instrumentation markets.

The Report Covers:

Market value data analysis of 2025 and forecast to 2035.
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the European life science instrumentation market. Based on the availability of data, information related to new products and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies.
Competitive strategies by identifying 'who-stands-where' in the market.

Product Code: OMR2023636

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
European Life Science Instrumentation Market Sales Analysis - Technology | End-Users | ($ Million)
European Life Science Instrumentation Market Sales Performance of Top Countries
1.1. Research Methodology
Primary Research Approach
Secondary Research Approach
1.2. Market Snapshot

2. Market Overview and Insights

2.1. Scope of the Study
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key European Life Science Instrumentation Industry Trends
- 2.2.2. Market Recommendations

3. Market Determinants

3.1. Market Drivers
- 3.1.1. Drivers For European Life Science Instrumentation Market: Impact Analysis
3.2. Market Pain Points and Challenges
- 3.2.1. Restraints For European Life Science Instrumentation Market: Impact Analysis
3.3. Market Opportunities

4. Competitive Landscape

4.1. Competitive Dashboard - European Life Science Instrumentation Market Revenue and Share by Manufacturers
Life Science Instrumentation Product Comparison Analysis
Top Market Player Ranking Matrix
4.2. Key Company Analysis
- 4.2.1. Analytik Jena GmbH + Co. KG
  - 4.2.1.1. Overview
  - 4.2.1.2. Product Portfolio
  - 4.2.1.3. Financial Analysis
  - 4.2.1.4. SWOT Analysis
  - 4.2.1.5. Business Strategy
- 4.2.2. bioMerieux SA
  - 4.2.2.1. Overview
  - 4.2.2.2. Product Portfolio
  - 4.2.2.3. Financial Analysis
  - 4.2.2.4. SWOT Analysis
  - 4.2.2.5. Business Strategy
- 4.2.3. Malvern Panalytical Ltd.
  - 4.2.3.1. Overview
  - 4.2.3.2. Product Portfolio
  - 4.2.3.3. Financial Analysis
  - 4.2.3.4. SWOT Analysis
  - 4.2.3.5. Business Strategy
- 4.2.4. Siemens Healthineers AG
  - 4.2.4.1. Overview
  - 4.2.4.2. Product Portfolio
  - 4.2.4.3. Financial Analysis
  - 4.2.4.4. SWOT Analysis
  - 4.2.4.5. Business Strategy
- 4.2.5. Thermo Fisher Scientific GmbH
  - 4.2.5.1. Overview
  - 4.2.5.2. Product Portfolio
  - 4.2.5.3. Financial Analysis
  - 4.2.5.4. SWOT Analysis
  - 4.2.5.5. Business Strategy
4.3. Top Winning Strategies by Market Players
- 4.3.1. Merger and Acquisition
- 4.3.2. Product Launch
- 4.3.3. Partnership And Collaboration

5. European Life Science Instrumentation Market Sales Analysis by Technology ($ Million)

5.1. Chromatography
5.2. Spectroscopy
5.3. Polymerase Chain Reaction (PCR)
5.4. Clinical Chemistry Analyzers
5.5. Immunoassays
5.6. Next Generation Sequencing (NGS)
5.7. Flow Cytometry
5.8. Microscopy
5.9. Others (Centrifuges, Electrophoresis)

6. European Life Science Instrumentation Market Sales Analysis by End-Users ($ Million)

6.1. Pharmaceutical & Biotechnology Companies
6.2. Research Institutes
6.3. Hospitals and Laboratories

7. Regional Analysis

7.1. European Life Science Instrumentation Market Sales Analysis - Technology | End-User | Country ($ Million)
Macroeconomic Factors for Europe
- 7.1.1. UK
- 7.1.2. Germany
- 7.1.3. Italy
- 7.1.4. Spain
- 7.1.5. France
- 7.1.6. Russia
- 7.1.7. Rest of Europe

8. Company Profiles

8.1. Analytik Jena GmbH + Co. KG
- 8.1.1. Quick Facts
- 8.1.2. Company Overview
- 8.1.3. Product Portfolio
- 8.1.4. Business Strategies
8.2. Anton Paar GmbH
- 8.2.1. Quick Facts
- 8.2.2. Company Overview
- 8.2.3. Product Portfolio
- 8.2.4. Business Strategies
8.3. bioMerieux SA
- 8.3.1. Quick Facts
- 8.3.2. Company Overview
- 8.3.3. Product Portfolio
- 8.3.4. Business Strategies
8.4. DiaSorin S.p.A.
- 8.4.1. Quick Facts
- 8.4.2. Company Overview
- 8.4.3. Product Portfolio
- 8.4.4. Business Strategies
8.5. Elementar GmbH
- 8.5.1. Quick Facts
- 8.5.2. Company Overview
- 8.5.3. Product Portfolio
- 8.5.4. Business Strategies
8.6. Immunodiagnostic Systems plc
- 8.6.1. Quick Facts
- 8.6.2. Company Overview
- 8.6.3. Product Portfolio
- 8.6.4. Business Strategies
8.7. Isotopx Ltd.
- 8.7.1. Quick Facts
- 8.7.2. Company Overview
- 8.7.3. Product Portfolio
- 8.7.4. Business Strategies
8.8. Knauer Wissenschaftliche Gerate GmbH
- 8.8.1. Quick Facts
- 8.8.2. Company Overview
- 8.8.3. Product Portfolio
- 8.8.4. Business Strategies
8.9. Malvern Panalytical Ltd.
- 8.9.1. Quick Facts
- 8.9.2. Company Overview
- 8.9.3. Product Portfolio
- 8.9.4. Business Strategies
8.10. Markes International Ltd.
- 8.10.1. Quick Facts
- 8.10.2. Company Overview
- 8.10.3. Product Portfolio
- 8.10.4. Business Strategies
8.11. Metrohm AG
- 8.11.1. Quick Facts
- 8.11.2. Company Overview
- 8.11.3. Product Portfolio
- 8.11.4. Business Strategies
8.12. Ortho Clinical Diagnostics
- 8.12.1. Quick Facts
- 8.12.2. Company Overview
- 8.12.3. Product Portfolio
- 8.12.4. Business Strategies
8.13. Precisa Switzerland (Precisa Gravimetrics AG)
- 8.13.1. Quick Facts
- 8.13.2. Company Overview
- 8.13.3. Product Portfolio
- 8.13.4. Business Strategies
8.14. Randox Laboratories Ltd.
- 8.14.1. Quick Facts
- 8.14.2. Company Overview
- 8.14.3. Product Portfolio
- 8.14.4. Business Strategies
8.15. Restek GmbH
- 8.15.1. Quick Facts
- 8.15.2. Company Overview
- 8.15.3. Product Portfolio
- 8.15.4. Business Strategies
8.16. Roche Diagnostics International Ltd.
- 8.16.1. Quick Facts
- 8.16.2. Company Overview
- 8.16.3. Product Portfolio
- 8.16.4. Business Strategies
8.17. Siemens Healthineers AG
- 8.17.1. Quick Facts
- 8.17.2. Company Overview
- 8.17.3. Product Portfolio
- 8.17.4. Business Strategies
8.18. SPECTRO Analytical Instruments GmbH
- 8.18.1. Quick Facts
- 8.18.2. Company Overview
- 8.18.3. Product Portfolio
- 8.18.4. Business Strategies
8.19. Techcomp Europe Ltd.
- 8.19.1. Quick Facts
- 8.19.2. Company Overview
- 8.19.3. Product Portfolio
- 8.19.4. Business Strategies
8.20. Thermo Fisher Scientific GmbH
- 8.20.1. Quick Facts
- 8.20.2. Company Overview
- 8.20.3. Product Portfolio
- 8.20.4. Business Strategies